Research
Teaching
Innovation

Endocrinology and nutrition

Researchers

  • Amaya Peñalva Arigita

    Endocrinology and nutrition

  • Gemma Francisco

    Endocrinology and nutrition

  • Irela López Cobo

    Endocrinology and nutrition

  • Luis Vila Ballester

    Endocrinology and nutrition

    Phd

  • Manuel Sahún De La Vega

    Endocrinology and nutrition

    Phd

  • Maria Lecha

    Endocrinology and nutrition

  • Mercè Albareda

    Endocrinology and nutrition

    Phd

  • Mercè Fernández Miró

    Endocrinology and nutrition

    Phd

  • Thank you Lara

    Endocrinology and nutrition

  • Raquel Barnes

    Endocrinology and nutrition

  • Sara Torrejón Jaramillo

    Endocrinology and nutrition

  • Vanesa Cabrejo

    Endocrinology and nutrition

Contact the group

Form

  • Aulinas A, Colom C, García-Patterson A, Ubeda J, María MA, Orellana I, Adelantado JM, de Leiva A, Corcoy R. 1247

    Smoking affects the oral glucose tolerance test profile and the relationship between glucose and HbA1c in gestational diabetes mellitus.

    Diabet Med. 2016;33(9):1240-4.

  • Chillarón JJ, Fernández-Miró M, Albareda M, Fontserè S, Colom C, Vila L, Pedro-Botet J, Flores Le-Roux JA. 1325

    Testosterone undecanoate improves lipid profile in patients with type 1 diabetes and hypogonadotrophic hypogonadism.

    Endocr J. 2016;63(9):849-855.

  • Völzke H, Caron P, Dahl L, de Castro JJ, Erlund I, Gaberšček S, Gunnarsdottir I, Hubalewska-Dydejczyk A, Ittermann T, Ivanova L, Karanfilski B, Khattak RM, Kusić Z, Laurberg P, Lazarus JH, Markou KB , Moreno-Reyes R, Nagy EV, Peeters RP, Pīrāgs V, Podoba J, Rayman MP, Rochau U, Siebert U, Smyth PP, Thuesen BH, Troen A, Vila L, Vitti P, Zamrazil V, Zimmermann MB. 1327

    Ensuring Effective Prevention of Iodine Deficiency Disorders.

    Thyroid. 2016;26(2):189-96.

  • Armario P, Blanch P, Castellanos P, Hernández del Rey R, Jericó C, Rap O, Martín Castillejos C, Mestrón A, Vila Ll.

    Resistant Hypertension in Diabetes Mellitus

    J Endocrinol Diab 2015; 2(3):5

  • Chillarón JJ, Fernández-Miró M, Albareda M, Vila L, Colom C, Fontserè S, Pedro-Botet J, Flores-Le Roux JA; TEST-DM1 Study Group. 1246

    Age, insulin requirements, waist circumference, and triglycerides predict hypogonadotropic hypogonadism in patients with type 1 diabetes.

    J Sex Med. 2015 Jan;12(1):76-82.

  • González C, Aulinas A, Colom C, Tundidor D, Mendoza L, Corcoy R, Mato E, Alcántara V, Urgell Rull E, de Leiva A. 1170

    Thyroglobulin as early prognostic marker to predict remission at 18-24 months in differentiated thyroid carcinoma.

    Clin Endocrinol (Oxf). 2014;80(2):301-6.

  • Morales Cl, Mauri M, Vila Ll. 1221

    Overcoming therapeutic inertia in the management of dyslipidemic patients: A challenge in daily clinical practice.

    Clin Invest Arterioscl. 2014;26(4):193-199.

  • Albareda M, Ravella A, Castelló M, Saborit S, Peramiquel L, Vila L. 1213

    Metabolic syndrome and its components in patients with psoriasis.

    Springerplus. 2014;3:612.

  • Puig-Domingo M, Vila L. 1041

    The Implications of Iodine and its supplementation during pregnancy in fetal brain development.

    Curr Clin Pharmacol. 2013;8(2):97-109.

  • Vila L, Velasco I, González S, Morales F, Sánchez E, Torrejon S, Soldevila B, Stagnaro-Green A, Puig-Domingo M. 1138

    Controversies in endocrinology: On the need for universal thyroid screening in pregnant women.

    Eur J Endocrinol. 2013:29;170(1):R17-30.

Projects

    • Year 2016
    • Comprehensive Care Center Dos de Maig Hospital

    Study on the sensory properties and acceptability of neutral commercial thickeners in elderly patients with oropharyngeal dysphagia,

    • DISTRICT ATTORNEY:

      Miriam Moreno, University of Vic- Central University of Catalonia and Vanesa Cabrejo Unit

    • TYPE E:

      PINE TREE

  • Endocrinology and nutrition

    Researcher
    • Year 2015
    • Sant Joan Despí Moisès Broggi Hospital

    EUthyroid – Towards the elimination of iodine deficiency and preventable thyroid-related diseases in Europe (Horizon - European Commission)

    • DISTRICT ATTORNEY:

      European Euthyroid Consortium

    • TYPE E:

      Horizon SEP-210177284

  • Endocrinology and nutrition

    Researcher
    • Year 2015
    • Sant Joan Despí Moisès Broggi Hospital

    Pragmatic real-world trial, 26 weeks with 6 months of extension, randomized, open, with 2 parallel arms, to evaluate the results of the clinical and health benefits of the transition to Toujeo ® compared to standard treatment insulins, in patients with Diabetes Mellitus Type 2 inadequately controlled treated with basal insulin,

    • DISTRICT ATTORNEY:

      Sanofi aventis Groupe

    • TYPE E:

      RD2004

  • Endocrinology and nutrition

    Researcher
    • Year 2015
    • Sant Joan Despí Moisès Broggi Hospital

    Observational study - diagnostic protocol and treatment of thyroid dysfunction in the pregnant population,

    • DISTRICT ATTORNEY:

      Sergio Donnay Candil (University Hospital Fundación de Alarcón)

    • TYPE E:

      PI

  • Endocrinology and nutrition

    Researcher
    • Year 2015
    • Sant Joan Despí Moisès Broggi Hospital

    Retrospective observational study on the management of therapeutic objectives in dyslipidemia in the units of lipids and vascular risk,

    • DISTRICT ATTORNEY:

      Althaia University Assistance Network of Manresa, Private Foundation

    • TYPE E:

      PI

  • Endocrinology and nutrition

    Researcher
    • Year 2015
    • Hospital General de l'Hospitalet

    Multinational, Prospective and Observational Study to Evaluate Uncovered Medical Needs Associated with the Use of Basal Insulin in Patients with Type 2 Diabetes with New or Recent Treatment with Basal Insulin,

    • DISTRICT ATTORNEY:

      Sanofi-Aventis, SA

    • TYPE E:

      PI

  • Endocrinology and nutrition

    Researcher
    • Year 2015
    • Sant Joan Despí Moisès Broggi Hospital

    Multinational, Prospective and Observational Study to Evaluate Uncovered Medical Needs Associated with the Use of Basal Insulin in Patients with Type 2 Diabetes with New or Recent Treatment with Basal Insulin,

    • DISTRICT ATTORNEY:

      Sanofi-Aventis, SA

    • TYPE E:

      PI

  • Endocrinology and nutrition

    Researcher
    • Year 2015
    • Sant Joan Despí Moisès Broggi Hospital

    Subcutaneous versus intravenous basal insulin in non-critical hospitalized diabetic patients receiving total parenteral nutrition,

    • DISTRICT ATTORNEY:

      Andalusian Public Foundation Progress and Health

    • TYPE E:

      RD2004

    • Year 2015
    • Sant Joan Despí Moisès Broggi Hospital

    Retrospective observational study on the management of therapeutic objectives in dyslipidemia in the units of lipids and vascular risk,

    • DISTRICT ATTORNEY:

      Althaia University Assistance Network of Manresa, Private Foundation

    • TYPE E:

      PINE TREE

    • Year 2015
    • L'Hospitalet General Hospital

    Multinational, Prospective and Observational Study to Evaluate Uncovered Medical Needs Associated with the Use of Basal Insulin in Patients with Type 2 Diabetes with New or Recent Treatment with Basal Insulin,

    • DISTRICT ATTORNEY:

      Sanofi-Aventis, SA

    • TYPE E:

      PINE TREE

Lines of action

  • Adequacy and effectiveness of primary prevention of arteriosclerotic disease
  • Iodine nutrition and thyroid function
  • Nutritional support: Nutritional support and education for complex chronic patients and treatment and control of patients with dysphagia
  • Impact of hypogonadotropic hypogonadism and its treatment in patients with type 1 diabetes
  • Metabolic control and well being in type 1 diabetes

Documents

Information of interest

Links

Accessibility by WAH